Champions Oncology, Inc. financial data

Symbol
CSBR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
855 N. Wolfe Street, Suite 619, Baltimore, Maryland
State of incorporation
Delaware
Fiscal year end
April 30
Former names
CHAMPIONS BIOTECHNOLOGY, INC. (to 3/30/2011), CHAMPIONS SPORTS INC (to 2/16/2007)
Latest financial report
Q4 2023 - Mar 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 72.4 % -32.5%
Debt-to-equity 2.51K % +697%
Return On Equity -851 % -2241%
Return On Assets -32.6 % -272%
Operating Margin -19.5 % -244%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.6M shares +0.26%
Common Stock, Shares, Outstanding 13.6M shares +0.26%
Entity Public Float 28M USD -36.4%
Common Stock, Value, Issued 14K USD 0%
Weighted Average Number of Shares Outstanding, Basic 13.6M shares +0.26%
Weighted Average Number of Shares Outstanding, Diluted 13.6M shares +0.26%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 49.2M USD -8.29%
Research and Development Expense 10.3M USD -8.31%
Selling and Marketing Expense 7.14M USD +5.44%
General and Administrative Expense 11.1M USD +7.75%
Operating Income (Loss) -9.61M USD -215%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.66M USD -214%
Income Tax Expense (Benefit) 70K USD +52.2%
Net Income (Loss) Attributable to Parent -9.73M USD -212%
Earnings Per Share, Basic -0.72 USD/shares -213%
Earnings Per Share, Diluted -0.72 USD/shares -227%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.47M USD -61.6%
Accounts Receivable, after Allowance for Credit Loss, Current 7.9M USD -1.96%
Assets, Current 13.2M USD -35.2%
Property, Plant and Equipment, Net 7.71M USD +10.4%
Operating Lease, Right-of-Use Asset 6.54M USD -13.9%
Goodwill 335K USD 0%
Other Assets, Noncurrent 185K USD +1133%
Assets 26.8M USD -25.9%
Accounts Payable, Current 4.76M USD +10.7%
Accrued Liabilities, Current 2.43M USD +19.6%
Contract with Customer, Liability, Current 13.3M USD +1.3%
Liabilities, Current 22M USD +5.64%
Operating Lease, Liability, Noncurrent 6.44M USD -16.4%
Other Liabilities, Noncurrent 439K USD -25.3%
Liabilities 28.8M USD -0.83%
Retained Earnings (Accumulated Deficit) -84.5M USD -13%
Stockholders' Equity Attributable to Parent -2.06M USD -129%
Liabilities and Equity 26.8M USD -25.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.99M USD -1947%
Net Cash Provided by (Used in) Financing Activities -590K USD
Net Cash Provided by (Used in) Investing Activities -668K USD +11.4%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 13.7M shares +1.15%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.25M USD -453%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.47M USD -61.6%
Deferred Tax Assets, Valuation Allowance 16.8M USD +8.09%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 16.8M USD +8.09%
Operating Lease, Liability 7.74M USD -12.7%
Payments to Acquire Property, Plant, and Equipment 668K USD -11.4%
Lessee, Operating Lease, Liability, to be Paid 14.7M USD -15.8%
Property, Plant and Equipment, Gross 16.5M USD +9.29%
Operating Lease, Liability, Current 1.31M USD +11.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.95M USD +2.11%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.9M USD +2.15%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7M USD -18.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.92M USD -0.75%
Deferred Tax Assets, Operating Loss Carryforwards 9.76M USD -15.5%
Current Income Tax Expense (Benefit) 68K USD +94.3%
Unrecognized Tax Benefits 181K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.87M USD -1.27%
Current State and Local Tax Expense (Benefit) 15K USD +50%
Current Federal Tax Expense (Benefit) 0 USD
Depreciation, Depletion and Amortization 1.85M USD -12.2%
Share-based Payment Arrangement, Expense 1.06M USD +25.9%